These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 19149110)
21. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma. Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390 [TBL] [Abstract][Full Text] [Related]
22. Ophthalmic generics--are they really the same? Chambers WA Ophthalmology; 2012 Jun; 119(6):1095-6. PubMed ID: 22656890 [No Abstract] [Full Text] [Related]
23. The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy. Kovacić Z; Stanić R; Rogosić V; Bojić L; Ivanisević M; Capkun V Acta Clin Croat; 2009 Mar; 48(1):31-3. PubMed ID: 19623869 [TBL] [Abstract][Full Text] [Related]
24. How I choose a prostaglandin analogue. Alward WL Am J Ophthalmol; 2009 Jan; 147(1):1-2. PubMed ID: 19100349 [No Abstract] [Full Text] [Related]
25. [Drug therapy in the treatment of glaucoma]. Thieme H Klin Monbl Augenheilkd; 2006 Sep; 223(9):R73-8; quiz R79-80. PubMed ID: 16986080 [No Abstract] [Full Text] [Related]
26. Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucoma. Schwartz GF Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S1-2. PubMed ID: 14697908 [No Abstract] [Full Text] [Related]
27. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023 [No Abstract] [Full Text] [Related]
28. Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. Leung DY; Kwong YY; Yuen HK Br J Ophthalmol; 2006 Feb; 90(2):250. PubMed ID: 16424552 [No Abstract] [Full Text] [Related]
29. Introduction: new insights on enhancing adherence to topical glaucoma medications. Friedman DS Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257 [No Abstract] [Full Text] [Related]
30. A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: the Proctor Lecture. Bito LZ Invest Ophthalmol Vis Sci; 2001 May; 42(6):1126-33. PubMed ID: 11328718 [No Abstract] [Full Text] [Related]
31. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma. Holló G; Kóthy P; Géczy A; Vargha P J Glaucoma; 2009; 18(4):288-92. PubMed ID: 19365193 [TBL] [Abstract][Full Text] [Related]
32. In search of improved prostaglandin treatment for glaucoma. Thygesen J Acta Ophthalmol Suppl (Oxf ); 2008; 242():5-6. PubMed ID: 18752508 [No Abstract] [Full Text] [Related]
33. Guanethidine in chronic simple glaucoma. Galloway NR; Birmingham AT Ann Ophthalmol; 1971 Aug; 3(8):901-3. PubMed ID: 4950481 [No Abstract] [Full Text] [Related]